Key result
Higher lead and cadmium exposure linked to ~19% higher cardiovascular mortality in US adults.
Cohort (n=15,421)
Yes
Answers are grounded in this paper and cite their sources.
Background: Lead and cadmium exposures have markedly declined in the USA following the implementation of large-scale public health policies and could have contributed to the unexplained decline in cardiovascular mortality in US adults. We evaluated the potential contribution of lead and cadmium exposure reductions to explain decreasing cardiovascular mortality trends occurring in the USA from 1988-94 to 1999-2004. Methods: Prospective study in 15 421 adults ≥40 years old who had participated in the National Health and Nutrition Examination Survey 1988-94 or 1999-2004. We estimated the amount of change in cardiovascular mortality over time that can be independently attributed to the intermediate pathway of changes in blood lead and urine cadmium concentrations. Results: There was a 42.0% decrease in blood lead and a 31.0% decrease in urine cadmium concentrations. The cardiovascular mortality rate ratio [95% confidence intervals (CIs)] associated with a doubling of metal levels was 1.19 (1.07, 1.31) for blood lead and 1.20 (1.09, 1.32) for urine cadmium. The absolute reduction in cardiovascular deaths comparing 1999-2004 to 1988-94 was 230.7 deaths/100 000 person-years, in models adjusted for traditional cardiovascular risk factors. Among these avoided deaths, 52.0 (95% CI 8.4, 96.7) and 19.4 (4.3, 36.4) deaths/100 000 person-years were attributable to changes in lead and cadmium, respectively. Conclusions: Environmental declines in lead and cadmium exposures were associated with reductions in cardiovascular mortality in US adults. Given the fact that lead and cadmium remain associated with cardiovascular disease at relatively low levels of exposure, prevention strategies that further minimize exposure to lead and cadmium may be needed.
No takes yet. Share an insight, caveat, or question.
Ruíz et al. (2017) conducted a cohort in Cardiovascular mortality (n=15,421). Blood lead and urine cadmium exposure vs. Lower exposure / 1988-1994 baseline period was evaluated on Cardiovascular mortality (RR 1.19, 95% CI 1.07-1.31). Declining blood lead and urine cadmium levels accounted for 52.0 and 19.4 avoided cardiovascular deaths/100,000 person-years, respectively, in US adults from 1988-94 to 1999-2004.
Synapse has enriched 10 related papers. Consider them for comparative context: